Patent classifications
C
C07
C07C
311/00
C07C311/30
C07C311/31
C07C311/34
C07C311/34
Compounds for inhibiting the activity of SARS-COV-2 spike glycoprotein
The present invention relates to compounds of formula (I) and its analogues (II) and (III): in which R.sub.1-R.sub.14, X, Y, Z.sub.1-Z.sub.4 are in the Summary of the Invention; capable of inhibiting the activity of RBD of SARS-COV-2 in its “closed” conformation before it binds with the human ACE2 receptor. The invention further provides a process for the preparation of compounds of the invention. ##STR00001##